On the public citation graph

Cryopreservation of Apheresis Platelets Treated with Riboflavin and UV Light

https://doi.org/10.2139/ssrn.4164077
0 signed · 28 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1001/jama.289.8.959openalex-extracted
Current and Emerging Infectious Risks of Blood Transfusions
inferredcites →https://doi.org/10.1016/j.transci.2012.01.008openalex-extracted
Characteristics of the THERAFLEX UV-Platelets pathogen inactivation system – An update
inferredcites →https://doi.org/10.1016/j.transci.2013.07.023openalex-extracted
Pathogen inactivation of whole blood and red cell components: An overview of concept, design, developments, criteria of acceptability and storage lesion
inferredcites →https://doi.org/10.1016/j.transci.2014.10.003openalex-extracted
Ebola virus convalescent blood products: Where we are now and where we may need to go
inferredcites →https://doi.org/10.1016/j.transci.2015.02.013openalex-extracted
Update on pathogen inactivation treatment of plasma, with the INTERCEPT Blood System: Current position on methodological, clinical and regulatory aspects
inferredcites →https://doi.org/10.1016/j.transci.2016.10.016openalex-extracted
Hepatitis E virus: Emerging from the shadows in developed countries
inferredcites →https://doi.org/10.1016/j.transci.2020.102754openalex-extracted
Optimizing the supply of whole blood-derived bioproducts through the combined implementation of cryopreservation and pathogen reduction technologies and practices: An overview
inferredcites →https://doi.org/10.1016/j.transci.2020.102788openalex-extracted
Emergency Supply Policy of Cryopreserved RBC and PLT: The Czech Republic Concept
inferredcites →https://doi.org/10.1046/j.1537-2995.1975.15576082215.xopenalex-extracted
A Study of Variables Affecting the Quality of Platelets Stored at “Room Temperature”
inferredcites →https://doi.org/10.1054/blre.2000.0129openalex-extracted
Reducing the risk of infection from plasma products: specific preventative strategies
inferredcites →https://doi.org/10.1111/bjh.16093openalex-extracted
The long and winding road to pathogen reduction of platelets, red blood cells and whole blood
inferredcites →https://doi.org/10.1111/j.1423-0410.2012.01662.xopenalex-extracted
Component pathogen inactivation: a critical review
inferredcites →https://doi.org/10.1111/j.1537-2995.2005.00647.xopenalex-extracted
Freezing human platelets with 6 percent dimethyl sulfoxide with removal of the supernatant solution before freezing and storage at −80°C without postthaw processing
inferredcites →https://doi.org/10.1111/j.1537-2995.2005.04350.xopenalex-extracted
Effects of a new pathogen‐reduction technology (Mirasol PRT) on functional aspects of platelet concentrates
inferredcites →https://doi.org/10.1111/j.1537-2995.2007.01594.xopenalex-extracted
Photochemical treatment of plasma with amotosalen and UVA light: process validation in three European blood centers
inferredcites →https://doi.org/10.1111/j.1537-2995.2009.02234.xopenalex-extracted
Inactivation of pathogens in single units of therapeutic fresh plasma by irradiation with ultraviolet light
inferredcites →https://doi.org/10.1111/j.1537-2995.2009.02272.xopenalex-extracted
Pathogen reduction of fresh plasma using riboflavin and ultraviolet light: effects on plasma coagulation proteins
inferredcites →https://doi.org/10.1111/j.1537-2995.2010.02694.xopenalex-extracted
A randomized controlled clinical trial evaluating the performance and safety of platelets treated with MIRASOL pathogen reduction technology
inferredcites →https://doi.org/10.1111/trf.12578openalex-extracted
The hemostatic activity of cryopreserved platelets is mediated by phosphatidylserine‐expressing platelets and platelet microparticles
inferredcites →https://doi.org/10.1111/trf.13511openalex-extracted
Storage of platelets at 4°C in platelet additive solutions prevents aggregate formation and preserves platelet functional responses
inferredcites →https://doi.org/10.1111/trf.14905openalex-extracted
Cryopreservation of buffy coat–derived platelet concentrates photochemically treated with amotosalen and UVA light
inferredcites →https://doi.org/10.1111/trf.15140openalex-extracted
Probable transmission of hepatitis E virus (HEV) via transfusion in the United States
inferredcites →https://doi.org/10.1111/trf.15177openalex-extracted
The use of cryopreserved platelets in the treatment of polytraumatic patients and patients with massive bleeding
inferredcites →https://doi.org/10.1111/trf.15204openalex-extracted
Cryopreservation of UVC pathogen‐inactivated platelets
inferredcites →https://doi.org/10.1111/trf.16324openalex-extracted
Cryopreservation of platelets treated with riboflavin and UV light and stored at −80 °C for 1 year
inferredcites →https://doi.org/10.1111/vox.12243openalex-extracted
Persistent aggregates in apheresis platelet concentrates
inferredcites →https://doi.org/10.1177/0310057x1304100104openalex-extracted
Frozen Blood Products: Clinically Effective and Potentially Ideal for Remote Australia
inferredcites →https://doi.org/10.1182/blood.v54.5.1023.1023openalex-extracted
Successful transfusion of platelets cryopreserved for more than 3 years
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.